FDA Recall D-0581-2025
Westminster Pharmaceuticals LLC · Nashville, TN
Class II Ongoing 281 days on record
Product
Metoprolol Tartrate Tablets, USP, 50 mg, 1000 Tablets, Rx Only, Manufactured by: Renata PLC (General Plant -2), Noyapara, Bhawal Mirzapur, Rajendrapur, Gazipur, 1700 Bangladesh, Distributed by: Westminster Pharmaceuticals, LLC, Nashville, TN 37217, NDC 69367-354-10
Reason for recall
CGMP Deviations: Presence of a nitrosamine, N-nitroso-metoprolol above the established Acceptable Daily Intake (ADI) level.
Recall record
- Recall number
D-0581-2025- Classification
- Class II
- Status
- Ongoing
- Voluntary or mandated
- Voluntary: Firm initiated
- Firm notification
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
- Distribution
- Nationwide in the USA.
- Recall initiated
- 2025-08-06
- Classified by FDA Center
- 2025-08-12
- FDA published
- 2025-08-20
- Recalling firm
- Westminster Pharmaceuticals LLC
- Firm location
- Nashville, TN
Drug identification
- Brand name(s)
- METOPROLOL TARTRATE
- Generic name(s)
- METOPROLOL TARTRATE
- Manufacturer(s)
- Westminster Pharmaceuticals, LLC
- NDC(s)
69367-354, 69367-355- Route(s)
- ORAL
Operational response
Class II recalls indicate possible temporary or reversible health consequences. Remove affected lots from active dispensing. Segregate inventory. Check the firm’s recall notification for guidance on patient outreach.
For the official FDA enforcement record, see FDA's Recall Search.